Business Description
Tus-Pharmaceutical Group Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000701
Share Class Description:
SZSE:000590: Class ACompare
Compare
Traded in other countries / regions
000590.China IPO Date
1996-01-19Description
Tus-Pharmaceutical Group Co Ltd is engaged in research and development of Chinese medicine recipes, prescriptions, and western medicine preparations. The company focuses on sectors like Chinese medicine, western medicine, and pharmaceutical marketing.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.76 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -61.91 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 3.52 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.7 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.67 | |||||
| 9-Day RSI | 64.9 | |||||
| 14-Day RSI | 66.18 | |||||
| 6-1 Month Momentum % | -7.89 | |||||
| 12-1 Month Momentum % | -27.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.22 | |||||
| Quick Ratio | 1.55 | |||||
| Cash Ratio | 0.87 | |||||
| Days Inventory | 284.81 | |||||
| Days Sales Outstanding | 16.09 | |||||
| Days Payable | 161.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.9 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.41 | |||||
| Operating Margin % | -3.62 | |||||
| Net Margin % | -2.78 | |||||
| FCF Margin % | -7.96 | |||||
| ROE % | -1.36 | |||||
| ROA % | -0.85 | |||||
| ROIC % | -2.85 | |||||
| ROC (Joel Greenblatt) % | -0.59 | |||||
| ROCE % | -0.2 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 212.5 | |||||
| PS Ratio | 5.7 | |||||
| PB Ratio | 2.93 | |||||
| Price-to-Tangible-Book | 4.72 | |||||
| Price-to-Operating-Cash-Flow | 359.3 | |||||
| EV-to-EBIT | -1248.3 | |||||
| EV-to-EBITDA | -1248.3 | |||||
| EV-to-Revenue | 6.29 | |||||
| EV-to-FCF | -70.95 | |||||
| Price-to-Projected-FCF | 4.13 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 28.33 | |||||
| Earnings Yield (Greenblatt) % | -0.08 | |||||
| FCF Yield % | -1.23 | |||||
| Forward Rate of Return (Yacktman) % | 16.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tus-Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 346.25 | ||
| EPS (TTM) (Â¥) | -0.04 | ||
| Beta | 0.9 | ||
| Volatility % | 46.21 | ||
| 14-Day RSI | 66.18 | ||
| 14-Day ATR (Â¥) | 0.566359 | ||
| 20-Day SMA (Â¥) | 8.539 | ||
| 12-1 Month Momentum % | -27.98 | ||
| 52-Week Range (Â¥) | 4.8 - 11.25 | ||
| Shares Outstanding (Mil) | 239.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tus-Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tus-Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tus-Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Tus-Pharmaceutical Group Co Ltd(SZSE:000590)'s stock price today?
The current price of SZSE:000590 is ¥8.50. The 52 week high of SZSE:000590 is ¥11.25 and 52 week low is ¥4.80.
When is next earnings date of Tus-Pharmaceutical Group Co Ltd(SZSE:000590)?
The next earnings date of Tus-Pharmaceutical Group Co Ltd(SZSE:000590) is .
Does Tus-Pharmaceutical Group Co Ltd(SZSE:000590) pay dividends? If so, how much?
Tus-Pharmaceutical Group Co Ltd(SZSE:000590) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers